Skip to main content

Table 2 Demographic, clinical, biochemical and angiographic characteristics in low and intermediate-high SYNTAX score (SS) group

From: The relationship between IL-6 levels and the angiographic severity of coronary artery disease following percutaneous coronary intervention in acute coronary syndrome patients

Variables SS ≤ 22 (n = 168) SS > 22 (n = 33) P value
Age, years 65 (57–71) 63 (58–75) .304
Male gender, n (%) 114 (67.9%) 22 (66.7%) .894
Hypertension, n (%) 107 (63.7%) 20 (60.6%) .737
Diabetes, n (%) 40 (23.8%) 9 (27.3%) .672
Smoking, n (%) 25 (14.9%) 5 (15.2%) .968
BMI, kg/m2 24.9 ± 3.5 24.2 ± 2.7 .312
WBC, 109/L 6.6 (5.3–8.0) 7.0 (5.6–8.8) .210
NEUT, 109/L 4.1 (3.3–5.4) 4.5 (3.6–5.9) .231
LYM, 109/L 1.7 (1.3–2.1) 1.9 (1.3–2.2) .833
NLR 2.4 (1.8–3.4) 2.6 (2.0–3.6) .277
Platelet, 109/L 174 (141–212) 185 (145–225) .275
RDW 12.9 (12.5–13.3) 12.8 (12.5–13.4) .741
Hemoglobin, g/L 129.8 ± 14.6 128.1 ± 23.7 .597
IL-6, pg/ml 6.5 (4.3–9.2) 14.0 (11.1–24.8) < .001
hs-CRP, mg/l 4.5 (1.3–9.0) 11.8 (8.7–20.0) < .001
Glucose, mmol/L 5.7 ± 2.5 5.6 ± 1.4 .830
TC, mmol/L 3.9 ± 1.0 4.0 ± 1.0 .578
Triglyceride, mmol/L 1.4 (1.0–2.0) 1.6 (1.2–1.8) .409
HDL-c, mmol/L 1.2 (1.1–1.4) 1.1 (1.0–1.3) .187
LDL-c, mmol/L 2.2 ± 0.8 2.4 ± 0.9 .176
apoB, g/L 0.8 (0.6–0.9) 0.9 (0.6–1.1) .138
apoA1, g/L 1.0 ± 0.2 1.1 ± 0.2 .571
Creatinine, umol/L 69.4 (57.7–85.2) 68.5 (57.2–87.6) .984
eGFR, ml/min 86.3 (67.4–113.1) 86.1 (66.8–104.2) .570
Albumin, g/L 39.4 (37.5–41.5) 38.6 (35.9–40.6) .091
Fibrinogen, g/L 3.0 (2.6–3.8) 3.4 (2.8–4.0) .129
D-Dimer, ug/ml 0.3 (0.2–0.5) 0.4 (0.2–0.6) .400
LVEF, % 62.0 (58.0–65.0) 62.0 (53.0–65.0) .744
SS 12.0 (7.0–15.8) 26.0 (23.5–28.5) < .001
SS II 24.5 (19.9–31.3) 30.5 (24.5–37.5) .001
rSS 2.0 (0–5.0) 10.0 (4.0–16.8) < .001
  1. BMI, Body Mass Index; WBC, white blood cell; NEUT, neutrophil; LYM, lymphocyte; NLR, the neutrophil to the lymphocyte ratio; RDW, red cell distribution width; IL-6, interleukin 6; hs-CRP, high-sensitivity C-reactive protein; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; apoB, apolipoprotein B; apoA1, apolipoprotein A1; apoB/apoA1, the apoB to the apoA1 ratio; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; SYNTAX, SYNergy between Percutaneous Coronary Intervention with TAXus and cardiac surgery; SS, SYNTAX score; SS II, SYNTAX score II; rSS, residual SYNTAX score